Esperion Therapeutics
ESPR
#7491
Rank
A$0.52 B
Marketcap
$2.63
Share price
5.70%
Change (1 day)
-17.34%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.23

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.45. In 2022 the company made an earnings per share (EPS) of -$5.60 an increase over its 2021 EPS that were of -$15.08.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.23-24.43%
2022-$5.60-62.87%
2021-$15.0880.38%
2020-$8.3650.14%
2019-$5.57-53.18%
2018-$11.897.41%
2017-$11.07110.81%
2016-$5.2547.35%
2015-$3.560.89%
2014-$3.5328.84%
2013-$2.74-89.3%
2012-$25.64
2002-$10.808.89%
2001-$9.92-83.77%
2000-$61.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$16.15 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.23-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.93-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$58.93-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.01-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.07-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA